Earnings Summary

Bio-techne Corp.’s revenue jumped 4.52% since last year same period to $289.46Mn in the Q3 2024. On a quarterly growth basis, Bio-techne Corp. has generated -5.44% fall in its revenue since last 3-months.

Bio-techne Corp.’s net profit fell -34.11% since last year same period to $33.6Mn in the Q3 2024. On a quarterly growth basis, Bio-techne Corp. has generated -17.22% fall in its net profits since last 3-months.

Bio-techne Corp.’s net profit margin fell -36.96% since last year same period to 11.61% in the Q3 2024. On a quarterly growth basis, Bio-techne Corp. has generated -12.46% fall in its net profit margins since last 3-months.

Bio-techne Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.38 - a -22.45% fall from last quarter’s estimates.

Bio-techne Corp.’s earning per share (EPS) estimates for the current year stand at 0.38.

Bio-techne Corp.’s earning per share (EPS) jumped 2.44% since last year same period to 0.42 in the Q3 2024. This indicates that the Bio-techne Corp. has generated 2.44% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Bio-techne Corp. declared 0.08 dividend per share during the earnings announcement for Q3 2024.